Skip to main content

Table 1 Description of the participants contributing to the baseline and biopsy cohorts. (both cohorts consist of HPV positive women

From: Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix

 

Baseline cohort (n = 1079 women)

Biopsy cohort (n = 201 women) *

Age at cohort entry

 30–39

539 (50.0%)

119 (59.2%)

 40–49

303 (28.1%)

47 (23.4%)

 50–59

134 (12.4%)

23 (11.4%)

 60–69

64 (5.9%)

7 (3.5%)

 70+

39 (3.6%)

5 (2.5%)

Smoking (at initial examination)

 Never

551 (51.1%)

98 (48.8%)

 Current

384 (35.6%)

82 (40.8%)

 Ex

110 (10.2%)

21 (10.4%)

 Unknown

34 (3.1%)

0 (0.0%)

Pap smear at cohort entry

 Normal

1079 (100%)

142 (70.7%)

 ASC-US

0

23 (11.4%)

 ASC-H

0

3 (1.5%)

 LSIL

0

33 (16.4%)

  1. *All women in the biopsy cohorts are also included in the baseline cohort